Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05815810 · ClinicalTrials.gov registry record · NA
Novel Delivery Method of Transgender Voice Modification Training Using a Mobile Application
A NA study, sponsored by Weill Medical College of Cornell University.
- Not yet
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT05815810 is a NA study that has not yet begun recruiting, run by Weill Medical College of Cornell University. The registered enrollment target is 50 participants.
The verdict
NCT05815810, a NA study, has not yet begun recruiting, sponsored by Weill Medical College of Cornell University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The investigators hypothesize that the mobile application they developed for transgender and gender diverse individuals (TGGD) will be equivalent or better than traditional speech therapy in improving voice quality. The investigators will measure both how the participants feel about their voices and how their voice actually sounds to see if the app is effective.
Interventions
- OTHER Attuned: A mobile application
- OTHER In-Person Voice Modification Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-10 |
| Est. Completion | 2031-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05815810
The ClinicalTrials.gov registry entry for NCT05815810 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Attuned: A mobile application is the first listed.
NCT05815810 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05815810 about?
NCT05815810 is a clinical study titled "Novel Delivery Method of Transgender Voice Modification Training Using a Mobile Application". The investigators hypothesize that the mobile application they developed for transgender and gender diverse individuals (TGGD) will be equivalent or better than traditional speech therapy in improving voice quality. The investigators will measure both how the participants feel about their voices and...
What is the current status of trial NCT05815810?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-10. Estimated completion is 2031-12.
What interventions are being tested in trial NCT05815810?
The interventions under investigation include: Attuned: A mobile application (OTHER), In-Person Voice Modification Therapy (OTHER).
Who is sponsoring clinical trial NCT05815810?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.